Compare · BE vs TMO
BE vs TMO
Side-by-side comparison of Bloom Energy Corporation (BE) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- BE operates in Energy, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $175.70B, about 2.3x BE ($74.98B).
- Over the past year, BE is up 1069.9% and TMO is up 15.6% - BE leads by 1054.3 points.
- BE has been more active in the news (20 items in the past 4 weeks vs 17 for TMO).
- Both have 25 recent analyst ratings on file.
- Company
- Bloom Energy Corporation
- Thermo Fisher Scientific Inc
- Price
- $250.93-4.86%
- $472.30-0.09%
- Market cap
- $74.98B
- $175.70B
- 1M return
- -3.12%
- -0.48%
- 1Y return
- +1069.90%
- +15.55%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 2018
- News (4w)
- 20
- 17
- Recent ratings
- 25
- 25
Bloom Energy Corporation
Bloom Energy Corporation designs, manufactures, and sells solid-oxide fuel cell systems for on-site power generation in the United States, Japan, China, India, and the Republic of Korea. The company offers Bloom Energy Server, a power generation platform that converts standard low-pressure natural gas, biogas, or hydrogen into electricity through an electrochemical process without combustion. It serves hospitals, healthcare companies, retailers, and data centers. The company was formerly known as Ion America Corp. and changed its name to Bloom Energy Corporation in September 2006. Bloom Energy Corporation was incorporated in 2001 and is headquartered in San Jose, California.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest BE
- Director Chambers John T sold $16,372,950 worth of shares (55,000 units at $297.69) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form SD filed by Bloom Energy Corporation
- SEC Form 144 filed by Bloom Energy Corporation
- Bloom Energy Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Director Warner Cynthia J was granted 1,063 shares, increasing direct ownership by 3% to 34,819 units (SEC Form 4)
- Director Zervigon Eddy was granted 1,063 shares, increasing direct ownership by 1% to 72,101 units (SEC Form 4)
- Director Burger Barbara J was granted 1,063 shares, increasing direct ownership by 3% to 38,940 units (SEC Form 4)
- Director Immelt Jeffrey R was granted 1,417 shares, increasing direct ownership by 0.62% to 231,158 units (SEC Form 4)
- Director Boskin Michael J was granted 1,063 shares, increasing direct ownership by 1% to 102,898 units (SEC Form 4)
- Director Bush Mary K was granted 1,063 shares, increasing direct ownership by 1% to 106,087 units (SEC Form 4)
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)